A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone ...
A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer.
Biofrontera Inc. announced that the last patient in its Phase 3 study, ALA-BCC-CT013, of Ameluz and RhodoLED PDT for treating superficial basal cell carcinoma (sBCC) completed their one-year ...